Treatment Options for Menorrhagia

First-Line Treatment Options

The Centers for Disease Control and Prevention recommends nonsteroidal anti-inflammatory drugs (NSAIDs) for 5-7 days and tranexamic acid for 5 days as the most effective non-hormonal treatment options for menorrhagia in patients who cannot take estrogen and are unwilling to use an IUD or implant 1, 2, 3
NSAIDs should be used for 5-7 days during menstruation as first-line therapy for menorrhagia, reducing menstrual blood loss by 20-60% 1, 2, 3
Tranexamic acid should be used for 5 days during menstruation as an alternative or additional first-line therapy, reducing menstrual blood loss by 20-60% 1, 2

The Centers for Disease Control and Prevention suggests that depot medroxyprogesterone acetate (DMPA) injectable can be considered if the patient is willing to use injectable contraception, with NSAIDs for 5-7 days used for heavy or prolonged bleeding with DMPA 1, 2, 3, 4

The Centers for Disease Control and Prevention recommends ruling out underlying conditions before initiating treatment, including checking for interactions with other medications, screening for sexually transmitted infections, and evaluating thyroid disorders 1, 2, 5

The Centers for Disease Control and Prevention suggests considering selective estrogen receptor modulators (SERMs) such as tamoxifen for 7-10 days during menstruation if first-line medical therapy fails 1, 2

The treatment algorithm should start with NSAIDs for 5-7 days during menstruation, followed by adding tranexamic acid for 5 days during menstruation if inadequate response, and considering progestin-only options if still inadequate 1, 2, 3, 4
Regular follow-up is essential to assess treatment efficacy and adjust therapy as needed, as recommended by the Centers for Disease Control and Prevention 1, 2